PPLPHARMA 180 PE (PUT) 24 February 2026 options price chart analysis Piramal Pharma Limited

PPLPHARMA 180 PE is trading at ₹ on 5:28am 04 Wed Feb 2026

10 minute average: ₹ 0
30 minute average: ₹ 0
Hourly average: ₹ 0
Day open: ₹
Day range: -
Open Interest: (0 K)

Munafa Value: 50 - This score indicates that the option of PPLPHARMA 180 PE does not have a definite trend. You can choose to wait till it shows a definite trend, or avoid it completely.

Lot size of PPLPHARMA is: 2625

Spot price of PPLPHARMA: 159.740 as on 04 Wed Feb 10:57am
Day open: 161.410 Range: 159.620 to 162.670

Option Price: PPLPHARMA PE 180 2026-02-24 on 04 Wed Feb 2026

Time

Option Price

Open Interest

Open

High

Low

option chart PPLPHARMA PE 180 2026-02-24

White line on the chart is the option premium, and gray line just under it is the open interest. Candle stick charts use day open, day high, day low, and current LTP of the premium. Please note that high low shadows are only plotted when a new high or low is made, otherwise, only candle body is plotted.

What is premium price of PPLPHARMA 180 PE PUT today?: Premium of PPLPHARMA 180 PE is 19.05 on 03 Feb 2026 PUT opened at 16.80 and traded inside a Low-High range of 16.80-21.89 today. Please click here table for more current prices.
What is open interest of PPLPHARMA 180 PUT PE today?: Open Interest of PPLPHARMA 180 PE is 162750 today. This has changed -2625.00 from previous day.
What is underlying price of PPLPHARMA 180 PE PUT today?: Underlying price of PPLPHARMA 180 PE PUT is 161.25 today.
What is lot size of PPLPHARMA 180 PUT PE today?: Lot size of PPLPHARMA 180 PUT PE is 2625.00
Is PPLPHARMA 180 PE PUT ITM or OTM or ATM?: PPLPHARMA 180 PUT PE is ITM PUT option (in the money). Only ITM options have intrinsic value in them, while OTM options have only time value in them.

Live Options price premium & chart analysis for PPLPHARMA 180 PE (PUT) 24 February 2026 options price chart analysis Piramal Pharma Limited

Piramal Pharma Limited PPLPHARMA trades in NSE under NSE

Underlying equity prev closing: 161.23

PPLPHARMA PUT PE available options strikes

PPLPHARMA PE 155 strike, PPLPHARMA PE 160 strike, PPLPHARMA PE 165 strike, All CE , All PE

PPLPHARMA 180 PUT PE available expiry dates

PPLPHARMA 24 Feb 2026 expiry PPLPHARMA 30 Mar 2026 expiry PPLPHARMA 28 Apr 2026 expiry

PPLPHARMA 180 PE Live prices

Premium of PUT (PE) of strike 180 is at: 19.05 on 03 Feb 2026
PUT opened at 16.80 and traded inside a Low-High range of 16.80-21.89 as on 03 Tue Feb 2026

The underlying equity is trading at 161.23 which means that PUT of strike 180 is ITM PUT option (in the money)

Lot size of PPLPHARMA Piramal Pharma Limited is 2625

Total Open Interest for PUT (PE) of strike 180 is 162,750

Munafa analysis PPLPHARMA 180 PE might not be profitable for buyers to buy this PUT, but this could be a good opportunity for sellers to make a quick profit.

Price action analysis of 180 PUT based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.

Click here to view most profitable CE and PE for Piramal Pharma Limited, both for buyers and sellers | PPLPHARMA Most Active Call Put Options

Date	Underlying price	PE price	PE open	PE high	PE low	PE volume	PE OI	OI Change
03 Tue Feb	161.23	19.05	16.80	21.89	16.80	-23	427,218,750	-1.6%
02 Mon Feb	155.06	25.00	28.92	30.00	25.00	-13	434,109,375	0%
01 Sun Feb	151.73	28.87	27.24	28.87	27.24	15	434,109,375	0%
30 Fri Jan	154.68	25.10	0.00	0.00	0.00	0	434,109,375	0%
29 Thu Jan	153.69	25.10	30.74	30.74	19.28	-9	434,109,375	-1.6%
28 Wed Jan	153.96	27.70	26.55	27.70	26.55	0	441,000,000	0%

Charts for PPLPHARMA 180 PUT PE options for Piramal Pharma Limited

Select an expiry and a strike price below to view charts for those options. PPLPHARMA All in One charts

Charts for:

Dark shadowed line on the chart below is the current SPOT price line of underlying equity. White line on the chart is the option closing price line. Candle sticks on the chart are the OHLC for the option.

PPLPHARMA further analysis